The Effect of Heparin and Its Preparations on Disseminated Intravascular Coagulation Mortality and Hospitalization: A Systematic Review

Background and Aim. Disseminated intravascular coagulation (DIC) is a critical clinical condition that is expressed by systemic activation of the homeostatic system, leading to elevation of thrombin deposition and result in microvascular thrombi. Heparin makes a good effect on hypercoagulability sta...

Full description

Saved in:
Bibliographic Details
Published in:International journal of clinical practice (Esher) 2022-07, Vol.2022, p.2226761-9
Main Authors: Omidkhoda, Navid, Abedi, Farshad, Ghavami, Vahid, Rahimi, Hossein, Samadi, Sara, Arasteh, Omid, Mohammadpour, Amir Hooshang
Format: Article
Language:English
Subjects:
Anticoagulants
Bias
Clinical trials
Cohort analysis
Coronaviruses
Disseminated intravascular coagulation
Disseminated Intravascular Coagulation - drug therapy
Embolisms
Heparin
Heparin - therapeutic use
Hospitalization
Humans
Infections
Medical Subject Headings-MeSH
Microvasculature
Mortality
Retrospective Studies
Review
Sepsis
Systematic review
Thrombin
Trauma
Viral infections
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background and Aim. Disseminated intravascular coagulation (DIC) is a critical clinical condition that is expressed by systemic activation of the homeostatic system, leading to elevation of thrombin deposition and result in microvascular thrombi. Heparin makes a good effect on hypercoagulability states through inhibition of thrombin. The present study aimed to summarize and discuss the results of randomized clinical trials and cohort studies regarding the effect of heparin and its preparations on DIC mortality and duration of hospitalization. Methods. The databases of PubMed, Scopus, Embase, and Web of Science were searched systematically up to November 2021. The quality of RCTs was assessed by Cochrane Collaboration’s tool and the risk of bias was assessed for cohort studies through NOS score. Results. Out of 3288 articles, eight studies were eligible to be included in this study. Our review retrieved six RCTs and two retrospective cohort studies consisting of 950 participants diagnosed by DIC. A significant effect of heparin on DIC mortality was identified in four studies. Furthermore, heparin was used as a control group in three studies. Conclusions. We concluded that administration of heparin and its preparations in DIC patients could reduce the mortality rate and duration of hospitalization, especially in the earlier stages of DIC.
ISSN:1368-5031
1742-1241
DOI:10.1155/2022/2226761